RITUXAN for Rheumatoid Arthritis Support Line: 1-877-474-8892.
 

Get a DVD & More

Join the RISE network today!
Join Now

Text Zoom
Glossary
ONONOFFOFF
Resources

Need answers to RA questions?

Call the RISE Support Line toll-free at
1-877-474-8892
Mon-Fri 8am-11pm ET or Sat 9am-1pm ET

Learn More
 

Need reimbursement information?

Call Genentech Access Solutions toll-free at
1-877-474-8892
Mon-Fri 9am - 8pm ET

Learn More

Need answers to questions about Rituxan?

Call the RISE Support Line toll-free at
1-877-474-8892
Then press 3
Mon-Fri 8am-11pm ET or Sat 9am-1pm ET

 

Need reimbursement information?

Call Genentech Access Solutions toll-free at
1-877-474-8892
Mon-Fri 9am - 8pm ET

Visit Genentech AccessSolutions.com

 

PrintSubsequent Courses of Treatment

Because rheumatoid arthritis (RA) is a chronic condition for which there is no cure, you'll eventually have to be treated again. For many people taking Rituxan, that can mean 6 months between treatments. But everyone is different. Some people go longer than 6 months, while others need treatment more often.

Keep in mind that the safety and efficacy of subsequent courses of Rituxan have not been established in controlled clinical trials.

Recognizing the difference between a symptom and a side effect is an important part of determining when your next treatment is needed. A side effect is an unwanted reaction to treatment, while a symptom is a result of your RA. A symptom is what helps you and your doctor determine when you'll receive your next course of treatment.

Seek immediate medical attention if you experience any side effects during or after your Rituxan infusions. And in the months to follow, talk to your doctor if you experience any symptoms of your RA. Again, a symptom is what helps you and your doctor determine when you'll receive your next course of treatment.

Learn more about Rituxan side effects

 

Next Understanding Rituxan's Safety Info


Please read the Medication Guide in HTML or PDF versions and the full prescribing information for more information.